Facebook
Instagram
Linkedin
Youtube
Start
News
Studio
Events
Newsletter
About BioStock
Contact us
Career
Search
BioStock
Start
News
Studio
Events
Newsletter
About BioStock
Contact us
Career
Home
Tags
Aqilion
Tag: Aqilion
Aqilion’s CEO: “We are driven by dealmaking and scientific data”
31 October, 2024
Aqilion and Merck sever ties
27 June, 2024
Aqilion aims for best-in-class with new programme
14 May, 2024
Aqilion on phase I results and potential IPO
10 November, 2023
Aqilion takes aim at eosinophilic esophagitis with AQ280
29 August, 2023
Chairman envisions continued success for Aqilion
6 July, 2023
Aqilion – Disrupting the Vicious Cycle of Chronic Inflammation
17 May, 2023
Expert Insights: Aqilion’s CEO on dealmaking
24 March, 2023
BioStock Investor Meeting starts today at 10.00
16 March, 2023
Aqilion and Merck join forces
16 February, 2023